Brief: Alligator Bioscience Appoints Søren Bregenholt As New CEO
March 18 (Reuters) - Alligator Bioscience AB ATORX.ST :
* APPOINTS SØREN BREGENHOLT AS NEW CEO
* SØREN BREGENHOLT WILL TAKE UP POSITION ON 1 JUNE 2021,
SUCCEEDING PER NORLÉN, WHO WILL REMAIN IN COMPANY
* IN ORDER TO FACILITATE TRANSITION, MALIN CARLSSON,
ALLIGATOR'S
COO, IS APPOINTED AS INTERIM CEO
Source text for Eikon: ID:nWkr3024PK
Further company coverage: ATORX.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alligator Bioscience AB
See all newsBrief: Alligator Bioscience Q1 Net Loss SEK 1.4 Million
Sweden's Alligator Bioscience posts Q1 net profit, narrows operating loss
Brief: Alligator Bioscience Q1 EBIT SEK -17.8 Million
Brief: Alligator Bioscience Signs LoI With Unicancer For Phase 3 Mitazalimab Development
Brief: Exercise Of Warrants Brings Alligator Bioscience Net Proceeds Of SEK 12 Mln